ZALANDO SE (ZAL.DE) Fundamental Analysis & Valuation

FRA:ZAL • DE000ZAL1111

Current stock price

21.03 EUR
-0.13 (-0.61%)
Last:

This ZAL.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. ZAL.DE Profitability Analysis

1.1 Basic Checks

  • ZAL had positive earnings in the past year.
  • In the past year ZAL had a positive cash flow from operations.
  • Each year in the past 5 years ZAL has been profitable.
  • ZAL had a positive operating cash flow in each of the past 5 years.
ZAL.DE Yearly Net Income VS EBIT VS OCF VS FCFZAL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

1.2 Ratios

  • ZAL has a Return On Assets (2.32%) which is comparable to the rest of the industry.
  • ZAL has a Return On Equity of 7.61%. This is in the better half of the industry: ZAL outperforms 63.27% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 5.75%, ZAL is in the better half of the industry, outperforming 61.22% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for ZAL is below the industry average of 9.06%.
  • The 3 year average ROIC (4.95%) for ZAL is below the current ROIC(5.75%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.32%
ROE 7.61%
ROIC 5.75%
ROA(3y)2.18%
ROA(5y)2.03%
ROE(3y)6.84%
ROE(5y)6.37%
ROIC(3y)4.95%
ROIC(5y)4.61%
ZAL.DE Yearly ROA, ROE, ROICZAL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • ZAL has a Profit Margin (1.74%) which is in line with its industry peers.
  • ZAL's Profit Margin has declined in the last couple of years.
  • ZAL has a Operating Margin (3.14%) which is in line with its industry peers.
  • In the last couple of years the Operating Margin of ZAL has declined.
  • The Gross Margin of ZAL (39.88%) is better than 61.22% of its industry peers.
  • In the last couple of years the Gross Margin of ZAL has remained more or less at the same level.
Industry RankSector Rank
OM 3.14%
PM (TTM) 1.74%
GM 39.88%
OM growth 3Y58.82%
OM growth 5Y-7.36%
PM growth 3Y120.55%
PM growth 5Y-9.26%
GM growth 3Y0.57%
GM growth 5Y-1.27%
ZAL.DE Yearly Profit, Operating, Gross MarginsZAL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ZAL.DE Health Analysis

2.1 Basic Checks

  • ZAL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for ZAL has been reduced compared to 1 year ago.
  • ZAL has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ZAL has been reduced compared to a year ago.
ZAL.DE Yearly Shares OutstandingZAL.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
ZAL.DE Yearly Total Debt VS Total AssetsZAL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • An Altman-Z score of 2.25 indicates that ZAL is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • ZAL's Altman-Z score of 2.25 is in line compared to the rest of the industry. ZAL outperforms 59.18% of its industry peers.
  • The Debt to FCF ratio of ZAL is 1.60, which is an excellent value as it means it would take ZAL, only 1.60 years of fcf income to pay off all of its debts.
  • ZAL's Debt to FCF ratio of 1.60 is amongst the best of the industry. ZAL outperforms 89.80% of its industry peers.
  • A Debt/Equity ratio of 0.45 indicates that ZAL is not too dependend on debt financing.
  • ZAL's Debt to Equity ratio of 0.45 is fine compared to the rest of the industry. ZAL outperforms 63.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 1.6
Altman-Z 2.25
ROIC/WACC0.91
WACC6.33%
ZAL.DE Yearly LT Debt VS Equity VS FCFZAL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

  • ZAL has a Current Ratio of 1.11. This is a normal value and indicates that ZAL is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.11, ZAL is in line with its industry, outperforming 40.82% of the companies in the same industry.
  • ZAL has a Quick Ratio of 1.11. This is a bad value and indicates that ZAL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ZAL has a Quick ratio (0.68) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 0.68
ZAL.DE Yearly Current Assets VS Current LiabilitesZAL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ZAL.DE Growth Analysis

3.1 Past

  • ZAL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.49%.
  • ZAL shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -1.19% yearly.
  • The Revenue has grown by 16.78% in the past year. This is quite good.
  • The Revenue has been growing by 9.11% on average over the past years. This is quite good.
EPS 1Y (TTM)-16.49%
EPS 3Y153.03%
EPS 5Y-1.19%
EPS Q2Q%-26.09%
Revenue 1Y (TTM)16.78%
Revenue growth 3Y6.07%
Revenue growth 5Y9.11%
Sales Q2Q%23.38%

3.2 Future

  • ZAL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.78% yearly.
  • ZAL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.71% yearly.
EPS Next Y75.79%
EPS Next 2Y53.1%
EPS Next 3Y41.19%
EPS Next 5Y35.78%
Revenue Next Year13.89%
Revenue Next 2Y10.04%
Revenue Next 3Y8.67%
Revenue Next 5Y7.71%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ZAL.DE Yearly Revenue VS EstimatesZAL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B
ZAL.DE Yearly EPS VS EstimatesZAL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

5

4. ZAL.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 25.96, the valuation of ZAL can be described as expensive.
  • ZAL's Price/Earnings ratio is in line with the industry average.
  • ZAL is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.64, which is the current average of the S&P500 Index.
  • ZAL is valuated correctly with a Price/Forward Earnings ratio of 14.77.
  • Based on the Price/Forward Earnings ratio, ZAL is valued a bit cheaper than the industry average as 67.35% of the companies are valued more expensively.
  • ZAL's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.36.
Industry RankSector Rank
PE 25.96
Fwd PE 14.77
ZAL.DE Price Earnings VS Forward Price EarningsZAL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ZAL indicates a somewhat cheap valuation: ZAL is cheaper than 63.27% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ZAL indicates a somewhat cheap valuation: ZAL is cheaper than 67.35% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 6.15
EV/EBITDA 6.24
ZAL.DE Per share dataZAL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • ZAL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ZAL's earnings are expected to grow with 41.19% in the coming years.
PEG (NY)0.34
PEG (5Y)N/A
EPS Next 2Y53.1%
EPS Next 3Y41.19%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ZAL.DE Dividend Analysis

5.1 Amount

  • ZAL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ZAL.DE Fundamentals: All Metrics, Ratios and Statistics

ZALANDO SE

FRA:ZAL (4/30/2026, 7:00:00 PM)

21.03

-0.13 (-0.61%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Industry Strength77.03
Industry Growth24
Earnings (Last)03-12
Earnings (Next)05-06
Inst Owners61.45%
Inst Owner ChangeN/A
Ins Owners10.12%
Ins Owner ChangeN/A
Market Cap5.56B
Revenue(TTM)12.35B
Net Income(TTM)215.10M
Analysts81.82
Price Target36.51 (73.61%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-56.31%
Min EPS beat(2)-62.87%
Max EPS beat(2)-49.76%
EPS beat(4)1
Avg EPS beat(4)194.29%
Min EPS beat(4)-62.87%
Max EPS beat(4)892.08%
EPS beat(8)4
Avg EPS beat(8)89.21%
EPS beat(12)5
Avg EPS beat(12)36.9%
EPS beat(16)7
Avg EPS beat(16)-17.74%
Revenue beat(2)1
Avg Revenue beat(2)0.66%
Min Revenue beat(2)-1.67%
Max Revenue beat(2)2.99%
Revenue beat(4)2
Avg Revenue beat(4)0.62%
Min Revenue beat(4)-1.67%
Max Revenue beat(4)2.99%
Revenue beat(8)4
Avg Revenue beat(8)0.1%
Revenue beat(12)5
Avg Revenue beat(12)-0.24%
Revenue beat(16)5
Avg Revenue beat(16)-0.47%
PT rev (1m)-0.41%
PT rev (3m)-1.54%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-3.76%
EPS NY rev (3m)-5.36%
Revenue NQ rev (1m)-0.92%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.23%
Revenue NY rev (3m)0.79%
Valuation
Industry RankSector Rank
PE 25.96
Fwd PE 14.77
P/S 0.45
P/FCF 6.15
P/OCF 4.93
P/B 1.97
P/tB 4.76
EV/EBITDA 6.24
EPS(TTM)0.81
EY3.85%
EPS(NY)1.42
Fwd EY6.77%
FCF(TTM)3.42
FCFY16.27%
OCF(TTM)4.26
OCFY20.27%
SpS46.73
BVpS10.7
TBVpS4.42
PEG (NY)0.34
PEG (5Y)N/A
Graham Number13.962 (-33.61%)
Profitability
Industry RankSector Rank
ROA 2.32%
ROE 7.61%
ROCE 9.01%
ROIC 5.75%
ROICexc 10.6%
ROICexgc 36.66%
OM 3.14%
PM (TTM) 1.74%
GM 39.88%
FCFM 7.32%
ROA(3y)2.18%
ROA(5y)2.03%
ROE(3y)6.84%
ROE(5y)6.37%
ROIC(3y)4.95%
ROIC(5y)4.61%
ROICexc(3y)12.52%
ROICexc(5y)11.66%
ROICexgc(3y)24.98%
ROICexgc(5y)20.08%
ROCE(3y)7.77%
ROCE(5y)7.23%
ROICexgc growth 3Y117.1%
ROICexgc growth 5Y0.15%
ROICexc growth 3Y56.14%
ROICexc growth 5Y-16.83%
OM growth 3Y58.82%
OM growth 5Y-7.36%
PM growth 3Y120.55%
PM growth 5Y-9.26%
GM growth 3Y0.57%
GM growth 5Y-1.27%
F-Score6
Asset Turnover1.33
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 1.6
Debt/EBITDA 1.6
Cap/Depr 54.95%
Cap/Sales 1.8%
Interest Coverage 7.59
Cash Conversion 142.19%
Profit Quality 420.18%
Current Ratio 1.11
Quick Ratio 0.68
Altman-Z 2.25
F-Score6
WACC6.33%
ROIC/WACC0.91
Cap/Depr(3y)65.4%
Cap/Depr(5y)91.31%
Cap/Sales(3y)2.12%
Cap/Sales(5y)2.59%
Profit Quality(3y)475.06%
Profit Quality(5y)438.13%
High Growth Momentum
Growth
EPS 1Y (TTM)-16.49%
EPS 3Y153.03%
EPS 5Y-1.19%
EPS Q2Q%-26.09%
EPS Next Y75.79%
EPS Next 2Y53.1%
EPS Next 3Y41.19%
EPS Next 5Y35.78%
Revenue 1Y (TTM)16.78%
Revenue growth 3Y6.07%
Revenue growth 5Y9.11%
Sales Q2Q%23.38%
Revenue Next Year13.89%
Revenue Next 2Y10.04%
Revenue Next 3Y8.67%
Revenue Next 5Y7.71%
EBIT growth 1Y-1.07%
EBIT growth 3Y68.47%
EBIT growth 5Y1.08%
EBIT Next Year109.62%
EBIT Next 3Y40.61%
EBIT Next 5Y30.18%
FCF growth 1Y102.06%
FCF growth 3Y102.84%
FCF growth 5Y26.66%
OCF growth 1Y72.19%
OCF growth 3Y34.79%
OCF growth 5Y16.39%

ZALANDO SE / ZAL.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ZALANDO SE?

ChartMill assigns a fundamental rating of 5 / 10 to ZAL.DE.


Can you provide the valuation status for ZALANDO SE?

ChartMill assigns a valuation rating of 5 / 10 to ZALANDO SE (ZAL.DE). This can be considered as Fairly Valued.


What is the profitability of ZAL stock?

ZALANDO SE (ZAL.DE) has a profitability rating of 5 / 10.


What is the valuation of ZALANDO SE based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ZALANDO SE (ZAL.DE) is 25.96 and the Price/Book (PB) ratio is 1.97.